Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.
Esbenshade AJ, Pentima MC, Zhao Z, Shintani A, Esbenshade JC, Simpson ME, Montgomery KC, Lindell RB, Lee H, Wallace A, Garcia KL, Moons KG, Friedman DL. Esbenshade AJ, et al. Among authors: garcia kl. Pediatr Blood Cancer. 2015 Feb;62(2):262-268. doi: 10.1002/pbc.25275. Epub 2014 Oct 18. Pediatr Blood Cancer. 2015. PMID: 25327666 Free PMC article.
A 3-Year-Old With Sudden-Onset Anisocoria After Playing Outside.
Garcia KL, Breazzano MP, Bond JB 3rd, Williams SR, Smith AT. Garcia KL, et al. Pediatr Emerg Care. 2018 Jun;34(6):e111-e114. doi: 10.1097/PEC.0000000000001513. Pediatr Emerg Care. 2018. PMID: 29851925 No abstract available.
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.
Halpern AB, Rodríguez-Arbolí E, Othus M, Garcia KA, Percival MM, Cassaday RD, Oehler VG, Becker PS, Appelbaum JS, Abkowitz JL, Orozco JJ, Keel SB, Hendrie PC, Scott BL, Ghiuzeli MC, Estey EH, Walter RB. Halpern AB, et al. Blood Adv. 2023 Sep 12;7(17):4950-4961. doi: 10.1182/bloodadvances.2023010392. Blood Adv. 2023. PMID: 37339483 Free PMC article. Clinical Trial.
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
Cassaday RD, Zarling LC, Garcia KA, Sala-Torra O, Stevenson PA, Martino CH, Liu YJ, Fang M, Percival MM, Halpern AB, Becker PS, Oehler VG, Shustov AR, Cooper JP, Orozco JJ, Hendrie PC, Walter RB, Radich JP, Soma LA, Estey EH. Cassaday RD, et al. Leuk Lymphoma. 2023 May;64(5):927-937. doi: 10.1080/10428194.2023.2189803. Epub 2023 Mar 20. Leuk Lymphoma. 2023. PMID: 36938892 Free PMC article. Clinical Trial.
27 results